Stella M. Sung

Aegea Biotechnologies, Inc. is a biotechnology company located in an undisclosed location. Aegea has been granted 11 US patents and 34 foreign equivalents worldwide. The American company's primary focus is on nucleic acid technology innovations, including molecular diagnostic assays, qPCR technologies, sequencing methods, and rapid point-of-care COVID-19 testing. The private company has complementary collaborations with Biocept and Tauriga Sciences for developing and commercializing its COVID-19 tests. The company was founded by Lyle J. Arnold, who has been the CEO since incorporation.

Pearl Street Venture Funds (Pearl Street) is a venture capital firm founded in 2003 by Tim J. Tichenor. The firm is headquartered in Indianapolis, Indiana.

Pearl Street Venture Funds (Pearl Street) is a venture capital firm founded in 2003 by Tim J. Tichenor. The firm is headquartered in Indianapolis, Indiana.

Pearl Street Venture Funds (Pearl Street) is a venture capital firm founded in 2003 by Tim J. Tichenor. The firm is headquartered in Indianapolis, Indiana.

Aegea Biotechnologies, Inc. is a biotechnology company located in an undisclosed location. Aegea has been granted 11 US patents and 34 foreign equivalents worldwide. The American company's primary focus is on nucleic acid technology innovations, including molecular diagnostic assays, qPCR technologies, sequencing methods, and rapid point-of-care COVID-19 testing. The private company has complementary collaborations with Biocept and Tauriga Sciences for developing and commercializing its COVID-19 tests. The company was founded by Lyle J. Arnold, who has been the CEO since incorporation.